Physician profile
Peter M Bittenbender
NPI 1508066614
$29,843.92
in general payments reported to CMS, 2019-2025
15 companies · $1,592 in 2025
The $1,592 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,502 · 2021: $215 · 2022: $340 · 2023: $301 · 2024: $9,869 · 2025: $1,592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,125 · Travel and Lodging: $2,297 · Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,125.00 |
| Travel and Lodging | $2,296.78 |
| Food and Beverage | $1,339.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $26,583.42 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,566.53 | 2019-2025 | Triclip, Cardiomems |
| Medtronic, INC. | $640.88 | 2021-2024 | Onyx Frontier, Euphora |
| Abiomed | $430.06 | 2019-2024 | Impella |
| Stryker Corporation | $226.73 | 2025 | Flowtriever, Artix Mt |
| Shockwave Medical, INC | $94.15 | 2025 | |
| Boston Scientific Corporation | $58.13 | 2020-2021 | |
| Inari Medical, INC. | $56.11 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $36.61 | 2019-2022 | |
| Cordis US Corp. | $35.93 | 2023-2024 | Mynx Control, Saber |
| Atricure, INC. | $35.25 | 2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Philips North America LLC | $26.83 | 2025 | Coronary Other |
| Csl Behring | $20.26 | 2022 | |
| Angiodynamics, INC. | $19.24 | 2025 | Angiovac |
| Ekos Corporation | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Bittenbender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.